Radiotherapy can induce anti-tumor immune responses, and a commonly studied approach is the combination of radiotherapy with immune checkpoint inhibitors (ICIs), with the most common being PD-1/PD-L1 and CTLA-4 inhibitors. This evidence concerns the gene CTLA4 and neoplasm.